B-Child: Phase I/II study of Bosutinib in pediatric patients with Chronic Myeloid Leukemia who are resistant or intolerant to at least one prior Tyrosine Kinase Inhibitor therapy

Project Details

Short titleB-Child: Phase I/II study of Bosutinib in pediatric patients with Chronic Myeloid Leukemia who are resistant or intolerant to at least one prior Tyrosine Kinase Inhibitor therapy
StatusActive
Effective start/end date21/09/18 → 20/09/29

Funding

  • Erasmus Univesitair Medisch Centrum